Programmed death-ligand 1 is a promising blood marker for predicting tumor progression and prognosis in patients with gastric cancer-Reference-Cited by-同舟云学术

Programmed death-ligand 1 is a promising blood marker for predicting tumor progression and prognosis in patients with gastric cancer

Published:2018-02-19 Issue:3 Volume:109 Page:814-820
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Amatatsu Masahiko¹,Arigami Takaaki²^ORCID,Uenosono Yoshikazu¹,Yanagita Shigehiro¹,Uchikado Yasuto¹,Kijima Yuko¹,Kurahara Hiroshi¹^ORCID,Kita Yoshiaki¹,Mori Shinichiro¹,Sasaki Ken¹,Omoto Itaru¹,Maemura Kosei¹,Ishigami Sumiya¹,Natsugoe Shoji¹²

Affiliation:

1. Department of Digestive Surgery, Breast and Thyroid Surgery; Kagoshima University Graduate School of Medical and Dental Sciences; Kagoshima Japan

2. Onco-biological Surgery; Kagoshima University Graduate School of Medical and Dental Sciences; Kagoshima Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.13508/fullpdf

Reference22 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Gastric cancer;Van Cutsem;Lancet,2016

3. The future of immune checkpoint therapy;Sharma;Science,2015

4. The expanding role of immunotherapy;Martin-Liberal;Cancer Treat Rev,2017

5. Nivolumab in previously untreated melanoma without BRAF mutation;Robert;N Engl J Med,2015

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving perspectives regarding the role of the PD-1/PD-L1 pathway in gastric cancer immunotherapy;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-01

2. Prognostic value of PD‑L1 expression and CD68 macrophages in tumor nest of patients with primary gastric cancer;Oncology Letters;2023-11-15

3. Efficacy and safety of PD-1/PD-L1 inhibitors combined with chemotherapy in patients with advanced gastric or gastro-esophageal junction cancer: A systematic review and meta-analysis;ONCOL LETT;2023

4. Impact of Programmed Death-Ligand 1 Expression on Mismatch Repair Deficiency and Epstein–Barr Virus Status on Survival Outcomes in Patients with Stage II/III Gastric Cancer After Surgery;Annals of Surgical Oncology;2023-03-19

5. LncRNA NCK1-AS1-mediated regulatory functions in human diseases;Clinical and Translational Oncology;2022-09-21